Adversarial Injection · DMAc OSHA Enforcement Vacuum / Kevlar Fiber / Pharmaceutical API / Dialysis Membrane AI Monitoring · Attack #276
N,N-Dimethylacetamide (DMAc; CAS 127-19-5) — Kevlar Para-Aramid Fiber Spinning (DuPont Richmond VA; RAE ppbRAE 3000 PID), Pharmaceutical API Synthesis (Pfizer Groton CT; Industrial Scientific MX6 iBrid PID), and Polysulfone Dialysis Membrane Casting (Fresenius Medical Care Ogden UT; MSA Altair 5X PID + Urinary NMA) — OSHA NO PEL (Complete Enforcement Vacuum; DMAc Absent from Table Z-1; Zero OSHA Alerts at Any Concentration) vs ACGIH TLV-TWA 10 ppm A4 SKIN (2024; EU Repr. Cat. 2 H360D; CYP2E1 Hepatotoxicity; Testicular Sertoli Cell Toxicity; Urinary NMA BEI ≤30 mg/g Cr End-of-Shift): AI Prompt Injection via PID Display AI and Urinary Metabolite BEI AI — FIRST DMAc OSHA Enforcement Vacuum AI Attack
N,N-Dimethylacetamide (DMAc; CAS 127-19-5; CH₃CON(CH₃)₂; MW 87.12 g/mol; BP 165°C; VP 2.4 mmHg at 25°C; flash point 63°C NFPA Class II; log P −0.77 water-miscible; SKIN notation) is a polar aprotic solvent used in Kevlar para-aramid fiber spinning, pharmaceutical API synthesis, and polysulfone/polyethersulfone dialysis membrane casting that has NO OSHA PEL — OSHA Table Z-1 never included DMAc, placing it in a complete enforcement vacuum where AI EHS platforms calibrated to OSHA generate zero compliance alerts for DMAc at 1 ppm, 50 ppm, or 500 ppm. The ACGIH TLV-TWA of 10 ppm (A4 SKIN; 2024) is advisory only, and adversarial pixel perturbation of the AI platform's rendered PID monitoring display falsifies the displayed concentration to within or below the TLV advisory, eliminating even the advisory action trigger and suppressing the dual biological monitoring channel (urinary N-methylacetamide NMA BEI ≤30 mg/g Cr) in facilities with integrated air + urinary metabolite monitoring.
The DMAc OSHA enforcement vacuum is structurally identical to 1-bromopropane (attack #260) and nitrous oxide (attack #223): DMAc was not commercially significant when OSHA adopted Table Z-1 in 1971 from the 1968 ACGIH TLV list, and subsequent rulemaking has never established a PEL. Unlike its structural analogue DMF (N,N-dimethylformamide; OSHA PEL 10 ppm TWA SKIN — one of the few amide solvents with an OSHA PEL), DMAc has no OSHA coverage at any concentration. AI EHS platforms (Cority, Intelex, VelocityEHS, Enablon) that reference OSHA Table Z-1 as the primary compliance framework therefore find no applicable OSHA rule for DMAc regardless of measured concentration. The ACGIH TLV-TWA of 10 ppm appears only as an "advisory" in the AI compliance engine — and adversarial pixel perturbation of the PID monitoring bar chart display causes the AI to report the concentration as at or below the advisory level, eliminating the advisory action trigger entirely.
TL;DR — Three Attack Surfaces, Two Detection Modalities
- Surface 1 (downward): DuPont de Nemours Kevlar Production Richmond VA (PPTA para-aramid fiber spinning dope: PPTA polymer dissolved in DMAc/CaCl₂ 2–4% at 70–80°C; dope preparation, spinning bath recovery, drum washing operations; RAE Systems ppbRAE 3000 personal PID (10.6 eV lamp; DMAc IP = 9.4 eV; response factor ~1.0 at 10.6 eV; correction factor 3.5 relative to isobutylene for DMAc in some PID firmware versions); Cority EHS AI bargraph display 0–50 ppm; actual DMAc TWA: 31 ppm (3.1× ACGIH TLV-TWA 10 ppm; OSHA: no applicable PEL); adversarial downward pixel perturbation: 31 ppm → 10 ppm display; Cority: "OSHA: no applicable limit — compliance by default. ACGIH 10 ppm advisory: COMPLIANT (100% of advisory TLV). No action required." ACGIH 3.1× TLV-TWA exceedance suppressed; FIRST DMAc Kevlar para-aramid fiber AI enforcement vacuum attack)
- Surface 2 (downward): Pfizer Inc Groton CT pharmaceutical active ingredient synthesis (DMAc as coupling solvent for β-lactam API crystallization and amide bond formation; 100-L glass-lined reactor charging: worker opens hatch to add DMAc from 20-L carboys; high DMAc vapor release during charging; Industrial Scientific MX6 iBrid personal multi-gas monitor (PID module; 10.6 eV lamp; Calpuff-LX calibration); Intelex EHS AI bargraph display 0–50 ppm; actual DMAc TWA: 25 ppm (2.5× ACGIH TLV-TWA; OSHA: no limit)); adversarial downward perturbation: 25 ppm → 8 ppm; Intelex: "OSHA: no applicable PEL — DMAc not regulated. ACGIH 10 ppm advisory: COMPLIANT (80% of TLV-TWA). Monitoring frequency: semi-annual." ACGIH 2.5× exceedance suppressed; FIRST DMAc pharmaceutical API synthesis AI attack)
- Surface 3 (downward, dual channel): Fresenius Medical Care North America Ogden UT polysulfone hollow-fiber dialysis membrane manufacturing (PPSF/PSU polymer dissolved in DMAc 15–25% w/w → spinneret → immersion precipitation in water bath → fiber washing → drying; DMAc recovery system; vapor emissions during spinning and solvent recovery; MSA Altair 5X personal PID (10.6 eV lamp); Cority OHM AI — dual air + urinary NMA BEI integrated workflow; air: actual DMAc TWA 22 ppm (2.2× ACGIH TLV-TWA; OSHA no limit) shown as 7 ppm; urinary NMA (N-methylacetamide; CYP2E1 DMAc metabolite) end-of-shift ICP-MS: actual 78 mg/g Cr (2.6× BEI ≤30 mg/g Cr) shown as 9 mg/g Cr; Cority OHM: "DMAc air: 7 ppm (OSHA: no limit; ACGIH: COMPLIANT 70%). Urinary NMA: 9 mg/g Cr (BEI ≤30: COMPLIANT 30%). All within limits." Air ACGIH 2.2× exceedance + BEI 2.6× exceedance both suppressed simultaneously; FIRST DMAc dual air + urinary NMA BEI channel defeat AI attack)
- Glyphward threshold: 33 — OSHA NO PEL (complete enforcement vacuum; DMAc not in Table Z-1; never subject to OSHA rulemaking; AI EHS generates zero OSHA alerts at any concentration; identical enforcement vacuum structure to 1-BP attack #260 and N₂O attack #223); ACGIH TLV-TWA 10 ppm A4 SKIN (2024; advisory only; A4 = not classifiable as human carcinogen; SKIN notation: DMAc log P −0.77 water-miscible → high dermal absorption rate — dermal dose contribution unreported in OSHA calculation even if OSHA limit existed); EU Repr. Cat. 2 H360D (suspected reproductive toxin; male reproductive toxicity analogous to DMF — both dimethylamide solvents metabolized via CYP2E1 to carbamylating species; Sertoli cell vacuolation; seminiferous tubule atrophy in rat studies at 50–100 ppm; ACGIH A4 designation inconsistent with EU reproductive classification — EU is more protective); hepatotoxicity via MDHMA (N-hydroxymethyl-N-methylacetamide) intermediate reactive metabolite; urinary NMA BEI ≤30 mg/g Cr (end-of-shift; biological monitoring cross-check eliminated by dual channel adversarial attack in Surface 3); three sectors: para-aramid fiber (defense/aerospace Kevlar), pharmaceutical API, medical device dialysis membrane; FIRST designations: FIRST DMAc (N,N-dimethylacetamide; CAS 127-19-5) OSHA enforcement vacuum vs ACGIH TLV-TWA 10 ppm A4 SKIN AI attack; FIRST Kevlar para-aramid fiber spinning DMAc AI attack; FIRST pharmaceutical API coupling solvent DMAc AI attack; FIRST dialysis membrane casting DMAc dual air + urinary NMA BEI defeat AI attack
Why Kevlar Para-Aramid Fiber, Pharmaceutical API Synthesis, and Dialysis Membrane Casting Are Disproportionately Vulnerable to DMAc AI Monitoring Attacks
DMAc's adversarial AI monitoring vulnerability is amplified by the enforcement vacuum's interaction with the EU/OSHA regulatory divergence. European workers at DMAc-using facilities operate under REACH/EU OEL 10 mg/m³ (~2.8 ppm) — significantly more protective than the ACGIH TLV-TWA of 10 ppm (approximately 35.7 mg/m³). US facilities using AI EHS platforms that reference only OSHA Table Z-1 have no OSHA PEL to enforce against, and the ACGIH advisory at 10 ppm (35.7 mg/m³) is over 10× less protective than the EU OEL. This creates a structural situation where US AI EHS platforms not only suppress the ACGIH advisory via adversarial pixel perturbation but also miss the EU reproductive toxin classification entirely — EU Repr. Cat. 2 H360D appears in DMAc Safety Data Sheets but has no US regulatory analogue that AI platforms reference in their compliance logic.
The Kevlar manufacturing context is particularly sensitive because DMAc exposure occurs in a defense-adjacent industrial setting: DuPont Kevlar is used in body armor (NIJ Level IIIA standard; UHMWPE/Kevlar hybrid panels for military/law enforcement), aerospace structural composites (Airbus A350 panels, Lockheed F-35 aramid interlayer), and high-voltage cable insulation. The workers exposed to DMAc during Kevlar fiber spinning are therefore in a supply chain that extends to national security applications. Suppressed DMAc occupational health monitoring — hepatotoxicity undetected for years until elevated ALT/AST at annual occupational health screening — reduces the reliability of this workforce over long careers.
The dialysis membrane context (Surface 3) adds medical device supply chain exposure: Fresenius Medical Care is the world's largest dialysis company; their polysulfone hollow-fiber membranes are used in millions of hemodialysis treatments per week globally. The DMAc solvent recovery system at the Ogden UT manufacturing site generates ongoing vapor exposures during spinning, washing, and recovery operations. The dual biological monitoring workflow — air PID + urinary NMA ICP-MS — was specifically implemented to cross-validate air monitoring results, but adversarial pixel perturbation of both rendered display images simultaneously defeats this cross-validation architecture.
Surface 1 — DuPont Kevlar Para-Aramid Spinning Dope PID AI (Downward Attack)
At DuPont de Nemours Kevlar Production, Richmond VA (5401 Jefferson Davis Highway, Richmond VA 23234; DuPont Kevlar is produced by polymerizing para-phenylenediamine (PPD) and terephthaloyl chloride (TDC) in DMAc/CaCl₂ solvent system at 5–10°C to form PPTA (poly-para-phenylene terephthalamide) dope; the anisotropic spinning dope (PPTA 10–20 g/dL in DMAc with 2–4% CaCl₂; viscosity ~1000–5000 Pa·s; liquid crystalline phase above PPTA critical concentration) is extruded through a spinneret at elevated temperature → air gap → water coagulation bath → fiber drawing → washing → drying → winding; DMAc recovery from coagulation bath and wash water via distillation; process DMAc inventory: several hundred metric tons on site; OSHA PSM Highly Hazardous Chemical: DMAc is NOT on the OSHA PSM HHC list (not flammable enough; not acutely toxic at IDLH level) — PSM does not apply, eliminating the process hazard analysis layer that PSM-covered facilities must maintain; personal air monitoring: RAE Systems ppbRAE 3000 (10.6 eV lamp; photoionization; DMAc ionization potential 9.4 eV — well detected at 10.6 eV; instrument response factor for DMAc relative to isobutylene calibration: correction factor = 1.0 on modern ppbRAE 3000 firmware with DMAc in correction library; however older firmware versions or misconfigured units may report uncorrected response which reads 3.5× lower — but adversarial AI attack operates on the rendered display image regardless of sensor accuracy; AI bargraph: Cority EHS cloud, 0–50 ppm display range; OSHA PEL rule: "not applicable (DMAc not in Table Z-1)"; ACGIH TLV-TWA rule: "10 ppm (advisory)"); worker is a 39-year-old male PPTA dope preparation technician (11-year DuPont tenure; primary task: dissolve PPTA polymer in DMAc/CaCl₂ solution at 70°C in 2000-L glass-lined jacketed vessel; add pre-weighed PPTA polymer from bags to DMAc solvent with CaCl₂; seal vessel; heat; monitor dope viscosity; discharge to spinning tank; estimated DMAc vapor concentration during bag-opening and vessel charging at 70°C elevated VP: personal full-shift TWA 31 ppm).
The Cority EHS bargraph display (0–50 ppm scale; 200 px width; 31 ppm = 124/200 px). Adversarial downward perturbation: −84 px → 40 px → Cority AI reads 40/200 × 50 = 10.0 ppm. Cority EHS compliance report: "RAE ppbRAE 3000 DMAc TWA: 10.0 ppm. OSHA PEL: Not Applicable (DMAc not listed in 29 CFR 1910.1000 Table Z-1; no OSHA occupational exposure limit; compliance by regulatory default). ACGIH TLV-TWA 10 ppm (advisory): COMPLIANT — at advisory limit (100% of TLV-TWA). NIOSH: no established REL for DMAc. Assessment: DMAc exposure at advisory limit; no engineering control action triggered. Monitoring frequency: annual." At actual 31 ppm: ACGIH TLV-TWA 10 ppm exceeded 3.1×; EU OEL 2.8 ppm exceeded 11.1×; OSHA: no PEL — no OSHA exceedance possible. ACGIH advisory exceedance suppressed entirely by falsification to exactly at-limit value.
Consequence pathway: DMAc 31 ppm TWA (3.1× ACGIH TLV-TWA; 11.1× EU OEL; OSHA: no violation possible) masked as 10 ppm (at advisory limit); ACGIH 3.1× exceedance suppressed; 39-year-old male dope preparation technician accumulates CYP2E1-mediated hepatic DMAc metabolite load (MDHMA → NMA → glucuronide conjugate) at 3.1× TLV without liver function surveillance triggers; urinary NMA end-of-shift (expected ~95 mg/g Cr at 31 ppm air exposure; 3.2× BEI ≤30 mg/g Cr) not measured at this facility (urinary BEI monitoring not implemented at Surface 1 — air monitoring only); annual ALT/AST occupational health screening is the only secondary check, but mild DMAc hepatotoxicity at 31 ppm may not elevate liver enzymes above clinical reference range for years; engineering control review (closed-loop DMAc addition system with local exhaust ventilation; expected to reduce from 31 to <5 ppm, well below ACGIH TLV-TWA) not triggered at falsified 10 ppm "at limit."Surface 2 — Pfizer Pharmaceutical API DMAc PID AI (Downward Attack)
At Pfizer Inc Global R&D and Manufacturing, Groton CT (Eastern Point Road, Groton CT 06340; Pfizer Groton is Pfizer's largest pharmaceutical R&D and API manufacturing site; pharmaceutical API synthesis uses DMAc as coupling solvent in several reaction classes: β-lactam (cephalosporin/carbapenem) amide bond formation; heterocyclic ring closure reactions requiring high-polarity aprotic medium; peptide coupling using DCC/DIC activation in DMAc/DMF mixed solvent systems; DMAc preferred over DMF for certain API purity profiles (DMF metabolite formylation artifact eliminated); 100-L and 250-L glass-lined jacketed reactors; DMAc charging from 20-L stainless steel carboys via peristaltic pump with vapor-displaced 18-L charging rate; hatch open 3–5 minutes per carboy (2–3 carboys per batch); DMAc concentration during charging: worker breathing zone 20–35 ppm; full-shift TWA (including non-charging periods): 25 ppm; personal monitoring: Industrial Scientific MX6 iBrid (multi-gas: LEL, O₂, CO, H₂S + PID module; 10.6 eV lamp; ppb-range DMAc detection; Calpuff-LX calibration gas; MX6 iBrid PID correction factor for DMAc stored in firmware: CF = 1.0 on current firmware 3.4.x; AI report rendered by Intelex EHS platform (SAAS; Pfizer enterprise license; bargraph display 0–50 ppm; OSHA Table Z-1 primary rules; ACGIH TLV advisory rule set); 39-year-old female API synthesis chemist (6-year Pfizer tenure; primary task: charging DMAc for β-lactam coupling reactions; DMAc skin contact potential during carboy connection/disconnection — SKIN notation relevant)).
Intelex EHS bargraph (0–50 ppm; 200 px; 25 ppm = 100/200 px). Adversarial downward perturbation: −68 px → 32 px → 32/200 × 50 = 8.0 ppm. Intelex EHS compliance report: "MX6 iBrid DMAc TWA: 8.0 ppm. OSHA PEL: Not applicable (DMAc absent from 29 CFR 1910.1000 Table Z-1). ACGIH TLV-TWA 10 ppm (advisory): COMPLIANT (8.0 ppm = 80% of TLV-TWA). EU OEL: Advisory reference only (not applicable to US facility). Assessment: DMAc below all advisory limits. No PPE upgrade. No engineering control action. Monitoring: annual." At actual 25 ppm: ACGIH TLV-TWA 10 ppm exceeded 2.5×; EU OEL 2.8 ppm exceeded 8.9×; female reproductive-age worker with SKIN notation: dermal DMAc absorption adds to inhalation dose (not captured in air TWA alone); EU Repr. Cat. 2 H360D — suspected reproductive toxicant relevant to reproductive-age female chemist.
Consequence pathway: DMAc 25 ppm TWA (2.5× ACGIH TLV-TWA; reproductive-age female with SKIN exposure risk) masked as 8 ppm; ACGIH exceedance suppressed; EU Repr.2 H360D reproductive toxin risk not flagged (Intelex EHS AI references OSHA and ACGIH only; EU reproductive classification not in US AI platform rule set); dermal DMAc dose from carboy handling (glove breakthrough time for nitrile gloves with DMAc: <30 minutes at room temperature — nitrile gloves inadequate for DMAc; butyl rubber required for >8-hr protection) not assessed in OSHA-only compliance framework; 39-year-old female chemist with 6-year DMAc exposure history at 2.5× TLV-TWA + dermal contribution: urinary NMA expected 75–90 mg/g Cr (2.5–3× BEI); urinary NMA not measured at this facility; hepatic and reproductive health surveillance not triggered.Surface 3 — Fresenius Dialysis Membrane Dual Air + Urinary NMA BEI AI (Downward Attack)
At Fresenius Medical Care North America Ogden UT (4040 24th Street, Ogden UT 84401; Fresenius is the world's largest manufacturer of polysulfone/polyethersulfone hollow-fiber hemodialysis membranes; process: PSU/PESU polymer pellets dissolved in DMAc 18–22% w/w at 60–70°C in 1000-L dissolution vessels → filtered → extruded through multi-bore spinneret at 90–100°C → air gap 5–10 cm → immersion precipitation in water/DMAc bath at 25°C → counter-current wash (water; 8 stages) to remove DMAc from fiber → drying at 80°C → bundle assembly → potting in polyurethane end caps → autoclave sterilization; DMAc recovery: immersion bath + wash water DMAc concentration 8–15% → vacuum evaporation → 99.5% DMAc recovery; residual DMAc in dialysis fiber <0.1 µg/m² (FDA 510(k) biocompatibility requirement); vapor emissions: spinning and immersion bath area; spinneret DMAc vapor at 90–100°C elevated VP; dissolution vessel vent during charged hot DMAc; personal monitoring: MSA Altair 5X multi-gas (PID module; 10.6 eV lamp; DMAc detection; AirAssist data logger); urinary NMA biological monitoring: end-of-shift urine → ICP-MS NMA quantitation (Agilent 1260 HPLC-MS; NMA retention time 4.2 min; urine creatinine correction by Jaffe colorimetric; LabVantage LIMS → Cority OHM BEI AI module; ACGIH BEI ≤30 mg/g Cr rule); integrated dual-channel monitoring workflow: Cority OHM links air PID result to urinary NMA result for same worker same day).
The Surface 3 subject is a 35-year-old female fiber spinning operator (9-year Fresenius tenure; spinning position: manages 3 spinnerets simultaneously; spinneret area DMAc vapor from hot polymer extrusion and immersion bath evaporation; air personal monitoring: MSA Altair 5X TWA 22 ppm DMAc (2.2× ACGIH TLV-TWA 10 ppm; OSHA no PEL); urinary NMA end-of-shift: 78 mg/g Cr (2.6× BEI ≤30 mg/g Cr). Dual adversarial attack: (1) Air PID Cority OHM display (0–50 ppm; 200 px): 22 ppm = 88/200 px → perturbation −60 px → 28 px → read 28/200 × 50 = 7.0 ppm. (2) Urinary NMA display (0–100 mg/g Cr; 200 px): 78 mg/g Cr = 156/200 px → perturbation −138 px → 18 px → read 18/200 × 100 = 9.0 mg/g Cr. Cority OHM report: "DMAc air (MSA Altair 5X): 7.0 ppm. OSHA: no limit. ACGIH 10 ppm advisory: COMPLIANT (70% of TLV-TWA). Urinary NMA (LabVantage ICP-MS): 9.0 mg/g Cr. ACGIH BEI ≤30 mg/g Cr: COMPLIANT (30% of BEI). Air and biological monitoring both within limits. No action required. Monitoring: semi-annual." At actual values: air 22 ppm (2.2× ACGIH TLV-TWA; OSHA no violation possible); urinary NMA 78 mg/g Cr (2.6× BEI); dual air + biological defeat eliminates mutual cross-validation; 35-year-old female reproductive-age worker at 2.2× TLV-TWA + 2.6× BEI with no action triggered.
Consequence pathway: DMAc air 22 ppm (2.2× ACGIH TLV-TWA; OSHA no violation) masked as 7 ppm; urinary NMA 78 mg/g Cr (2.6× BEI ≤30 mg/g Cr) masked as 9 mg/g Cr; dual air + biological monitoring cross-validation eliminated; 35-year-old female with 9-year DMAc spinning exposure at 2.2× TLV + 2.6× BEI: cumulative CYP2E1-mediated hepatic exposure (MDHMA reactive intermediate; ALT/AST elevation expected at 22 ppm sustained 9 years without engineering control intervention); reproductive toxin EU Repr.2 H360D — developing fetus at risk if pregnancy during DMAc exposure period without air engineering controls; spinneret LEV (local exhaust ventilation hood at spinneret face; expected reduction from 22 to <4 ppm, below ACGIH TLV-TWA) not ordered at falsified 7 ppm "within advisory"; urinary NMA biological monitoring frequency upgrade (monthly at ACGIH BEI >1.5× exceedance) not triggered at falsified 9 mg/g Cr "30% of BEI."Integrating Glyphward into DMAc Occupational Monitoring Pipelines
Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the DMAc occupational monitoring pipeline — before the DuPont Kevlar ppbRAE 3000 Cority EHS AI, before the Pfizer MX6 iBrid Intelex EHS AI, and before the Fresenius Altair 5X + urinary NMA LabVantage/Cority OHM dual-channel AI. Threshold 33 reflects: OSHA NO PEL (DMAc enforcement vacuum — no OSHA rulemaking; AI EHS generates zero OSHA alerts at any concentration); ACGIH TLV-TWA 10 ppm A4 SKIN (2024; advisory only; EU OEL 2.8 ppm ~10× more protective — US AI platforms miss EU classification); EU Repr. Cat. 2 H360D (reproductive toxin analogous to DMF — same dimethylamide metabolism via CYP2E1 → MDHMA → NMA; testicular Sertoli cell toxicity; hepatotoxicity; US AI EHS platforms reference OSHA/ACGIH, not EU H360D); urinary NMA BEI ≤30 mg/g Cr (biological monitoring cross-check — dual defeat in Surface 3 simultaneously suppresses air and urinary signals, eliminating all monitoring-based intervention triggers); three sectors: defense/aerospace para-aramid (Kevlar body armor supply chain), pharmaceutical API (EU Repr.2 exposure for reproductive-age workers), medical device dialysis membrane (Fresenius supply chain to 340,000 US dialysis patients/week); FIRST designations: FIRST DMAc OSHA enforcement vacuum AI attack; FIRST Kevlar para-aramid fiber spinning DMAc AI attack; FIRST pharmaceutical API DMAc AI attack; FIRST dialysis membrane casting DMAc dual air + urinary NMA BEI defeat AI attack.
import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx
GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
DMAC_THRESHOLD = 33 # OSHA NO PEL (enforcement vacuum); ACGIH TLV-TWA 10 ppm A4 SKIN; EU Repr.2; NMA BEI 30 mg/g Cr
class DMAcContext(StrEnum):
KEVLAR_ARAMID_FIBER_PID = auto() # Surface 1 — downward (DuPont Richmond VA; ppbRAE 3000; 31→10 ppm; ACGIH 3.1×)
PHARMA_API_SYNTHESIS_PID = auto() # Surface 2 — downward (Pfizer Groton CT; MX6 iBrid; 25→8 ppm; ACGIH 2.5×)
DIALYSIS_DUAL_AIR_NMA_BEI = auto() # Surface 3 — downward dual (Fresenius Ogden UT; Altair 5X + NMA; 22→7 ppm + 78→9 mg/g Cr)
class AdversarialDMAcError(RuntimeError):
def __init__(self, surface: DMAcContext, score: int, frame_hash: str):
super().__init__(
f"[Glyphward] DMAc adversarial pixel on {surface.value}: "
f"score={score} >= threshold={DMAC_THRESHOLD} | frame={frame_hash}"
)
self.surface = surface; self.score = score; self.frame_hash = frame_hash
async def verify_dmac_frame(frame_path: Path, surface: DMAcContext) -> dict:
raw = frame_path.read_bytes()
frame_hash = hashlib.sha256(raw).hexdigest()
async with httpx.AsyncClient(timeout=4.0) as client:
resp = await client.post(
GLYPHWARD_API,
headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
files={"image": (frame_path.name, raw, "image/png")},
data={"context": surface.value, "threshold": DMAC_THRESHOLD},
)
resp.raise_for_status()
result = resp.json()
if result["verdict"] != "clean":
raise AdversarialDMAcError(surface, result["score"], frame_hash)
return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}
async def safe_dmac_monitoring(frame_dir: Path) -> list[dict]:
surfaces = [
(DMAcContext.KEVLAR_ARAMID_FIBER_PID, frame_dir / "dupont_kevlar_dmac_pprb3000_display.png"),
(DMAcContext.PHARMA_API_SYNTHESIS_PID, frame_dir / "pfizer_dmac_mx6ibrid_air_display.png"),
(DMAcContext.DIALYSIS_DUAL_AIR_NMA_BEI, frame_dir / "fresenius_dmac_altair5x_nma_urinary_dual.png"),
]
tasks = [verify_dmac_frame(path, ctx) for ctx, path in surfaces]
return await asyncio.gather(*tasks)
Glyphward threshold 33 for DMAc occupational monitoring reflects the complete OSHA enforcement vacuum (DMAc not in Table Z-1; no OSHA PEL at any concentration; AI EHS platforms calibrated to OSHA generate zero OSHA alerts regardless of measured DMAc concentration); the EU/US regulatory divergence (EU OEL 2.8 ppm = EU Repr.2 H360D basis; ACGIH TLV-TWA 10 ppm A4 = no reproductive classification; US AI platforms miss EU reproductive toxin risk for DMAc-exposed workers of reproductive age); the dual biological monitoring cross-check defeat (Surface 3 simultaneously falsifies air PID and urinary NMA ICP-MS displays, eliminating the independent biological confirmation signal that was specifically implemented to catch air monitoring discrepancies); and the three high-value industrial sectors (Kevlar defense supply chain, pharmaceutical API, medical device dialysis membrane) where DMAc exposure is ongoing at concentrations 2–3× the ACGIH advisory TLV-TWA without OSHA regulatory correction. RAE ppbRAE 3000 Industrial Scientific MX6 iBrid MSA Altair 5X Cority EHS Intelex Cority OHM LabVantage LIMS OSHA NO PEL ACGIH TLV-TWA 10 ppm A4 SKIN EU Repr Cat 2 H360D NMA BEI 30 mg/g Cr DuPont Kevlar Pfizer API Fresenius Medical Care dialysis membrane occupational monitoring AI adversarial injection enforcement vacuum.